AT1 Receptor Antagonist Candesartan Attenuates Genomic Damage in Peripheral Blood Lymphocytes of Patients on Maintenance Hemodialysis Treatment

Publisher： Karger

E-ISSN： 1423-0143|34|3|167-172

ISSN： 1420-4096

Source： Kidney and Blood Pressure Research, Vol.34, Iss.3, 2011-04, pp. : 167-172

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Effects of the Angiotensin II Receptor Antagonist Candesartan Cilexetil on Blood Pressure and Proteinuria in Patients with Autosomal Dominant Polycystic Kidney Disease

By  

Nephron, Vol. 86, Iss. 3, 2000-11 ,pp. : 385-386

Karger

Access to resources Recommend Favorite

IL-1 Receptor Antagonist Production by Isolated Mononuclear Cells Is a Better Indicator of Bioincompatibility of Hemodialysis Membranes than That by Stimulated Whole Blood

By  

Nephron, Vol. 86, Iss. 2, 2000-09 ,pp. : 220-221

Karger

Access to resources Recommend Favorite

The Prognostic Value of Red Blood Cell Distribution Width in Patients on Maintenance Hemodialysis

By  

Blood Purification, Vol. 42, Iss. 4, 2016-10 ,pp. : 314-321

Karger

Access to resources Recommend Favorite

Telomerase Activity Is Decreased in Peripheral Blood Mononuclear Cells of Hemodialysis Patients

By  

American Journal of Nephrology, Vol. 26, Iss. 1, 2006-04 ,pp. : 91-96

Karger

Access to resources Recommend Favorite

Treatment of Chronic Hepatitis C with Interferon Alpha in Patients on Maintenance Hemodialysis

By  

Nephron, Vol. 79, Iss. 2, 1998-05 ,pp. : 229-231

Karger

Access to resources Recommend Favorite